Cagrilintide Cagrilintide is an investigational amylin receptor agonist developed for the treatment of obesity and weight management
Domains assessed included randomization process, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias
Dopamine: Neurotransmitter for motion and emotion Dopamine acts as a neurotransmitter in the brain, transmitting a signal from one neuron to the next
Gastrointestinal symptoms like vomiting are also common
However, the effectiveness depends on the peptides size, stability, and formulation